Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Coronary Artery Disease and CYP2C9[original query] |
---|
CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease--the ENCORE Trials. Atherosclerosis 2009 Dec 207 (2): 476-9. Hermann M, Hellermann J P, Quitzau K, Hoffmann M M, Gasser T, Meinertz T, Münzel T, Fleming I, Lüscher T |
Impact of CYP2C8 and 2C9 polymorphisms on coronary artery disease and myocardial infarction in the LURIC cohort. Pharmacogenomics 2010 Oct 11 (10): 1359-65. Haschke-Becher Elisabeth, Kirchheiner Julia, Trummer Olivia, Grünbacher Gerda, Kainz Alexander, Boehm Bernhard O, März Winfried, Renner Wilfri |
Cytochrome P450 2B6 and 2C9 genotype polymorphism--a possible cause of prasugrel low responsiveness. Thrombosis and haemostasis 2013 Jul 110 (1): 131-40. Franken Cora C, Kaiser Andreas F C, Krüger Jan C, Overbeck Kristina, Mügge Andreas, Neubauer Hor |
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC. Cardiovascular interventions 2013 Nov 6 (11): 11. Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G |
Factors influencing quality of anticoagulation control and warfarin dosage in patients after aortic valve replacement within the 3 months of follow up. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2016 Jun 67 (3): 385-93. Wypasek E, Mazur P, Bochenek M, Awsiuk M, Grudzien G, Plincer D, Undas |
Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease. Archives of medical sciences. Atherosclerotic diseases 2017 2 e68-e75. Shek Aleksandr B, Kurbanov Ravshanbek D, Abdullaeva Guzal J, Nagay Aleksandr V, Hoshimov Shavkat U, Nizamov Ulugbek I, Ziyaeva Adolat V, Alieva Rano |
Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites. Acta pharmacologica Sinica 2018 Jun . Bai Xue, Zhang Bin, Wang Ping, Wang Guan-Lei, Li Jia-Li, Wen Ding-Sheng, Long Xing-Zhen, Sun Hong-Shuo, Liu Yi-Bin, Huang Min, Zhong Shi-Lo |
Eicosanoids via CYP450 and cardiovascular disease: Hints from genetic and nutrition studies. Prostaglandins & other lipid mediators 2018 10 139 41-47. Fava Cristiano, Bonafini Sa |
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. European heart journal. Cardiovascular pharmacotherapy 2019 Sep . Lewis Joshua P, Backman Joshua D, Reny Jean-Luc, Bergmeijer Thomas O, Mitchell Braxton D, Ritchie Marylyn D, Déry Jean-Pierre, Pakyz Ruth E, Gong Li, Ryan Kathleen, Kim Eun-Young, Aradi Daniel, Fernandez-Cadenas Israel, Lee Ming Ta Michael, Whaley Ryan M, Montaner Joan, Gensini Gian Franco, Cleator John H, Chang Kiyuk, Holmvang Lene, Hochholzer Willibald, Roden Dan M, Winter Stefan, Altman Russ B, Alexopoulos Dimitrios, Kim Ho-Sook, Gawaz Meinrad, Bliden Kevin P, Valgimigli Marco, Marcucci Rossella, Campo Gianluca, Schaeffeler Elke, Dridi Nadia P, Wen Ming-Shien, Shin Jae Gook, Fontana Pierre, Giusti Betti, Geisler Tobias, Kubo Michiaki, Trenk Dietmar, Siller-Matula Jolanta M, Ten Berg Jurriën M, Gurbel Paul A, Schwab Matthias, Klein Teri E, Shuldiner Alan R, |
Personalized rosuvastatin therapy in problem patients with partial statin intolerance. Archives of medical sciences. Atherosclerotic diseases 2018 3 e83-e89. Shek Aleksandr B, Kurbanov Ravshanbek D, Alieva Rano B, Abdullaeva Guzal J, Nagay Aleksandr V, Abdullaev Alisher A, Hoshimov Shavkat U, Nizamov Ulugbek |
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Molecular diagnosis & therapy 2021 8 25 (6): 735-755. Hirata Thiago Dominguez Crespo, Dagli-Hernandez Carolina, Genvigir Fabiana Dalla Vecchia, Lauschke Volker Martin, Zhou Yitian, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Cres |
Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes. Frontiers in pharmacology 2021 2 11 593982. Xu Ru-Jun, Kong Wei-Min, An Xiao-Fei, Zou Jian-Jun, Liu Li, Liu Xiao-Do |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: